BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 989256)

  • 1. Intrathecal pharmacotherapy in coma.
    Ogashiwa M; Takeuchi K
    Acta Neurochir (Wien); 1976; 34(1-4):37-44. PubMed ID: 989256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the intrathecal pharmacotherapy. Part I: CDP-choline.
    Ogashiwa M; Takeuchi K; Hara M; Tanaka Y; Okada J
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):327-35. PubMed ID: 1242132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal administration of CDP-choline into the lower lumbar subarachnoid space in two patients with post-traumatic akinetic mutism.
    Tanji H; Takahashi M; Masu K; Kawaguchi Y; Abe H
    Fukushima J Med Sci; 1976 Mar; 22(1-2):31-47. PubMed ID: 1037478
    [No Abstract]   [Full Text] [Related]  

  • 4. CDP-choline in the treatment of cranio-encephalic traumata.
    Lozano R
    J Neurol Sci; 1991 Jul; 103 Suppl():S43-7. PubMed ID: 1940966
    [No Abstract]   [Full Text] [Related]  

  • 5. [A precursor of phospholipids in the treatment of severe traumatic comas].
    Cohadon F; Richer E; Poletto B
    Neurochirurgie; 1982; 28(4):287-90. PubMed ID: 6759958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of citicoline in high dosages in acute cerebrovascular disease].
    Centrone G; Ragno G; Calicchio G
    Minerva Med; 1986 Mar; 77(11):371-3. PubMed ID: 3703329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diurnal variation of serum cortisol and CDP-choline treatment of patients in the vegetative state].
    Saito Y; Kitane Y; Kawaguchi N; Nojima T; Takahashi
    Horumon To Rinsho; 1975 Oct; 23(10):1021-8. PubMed ID: 1238182
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of CDP-choline on the recovery of patients with head injury.
    Calatayud Maldonado V; Calatayud Pérez JB; Aso Escario J
    J Neurol Sci; 1991 Jul; 103 Suppl():S15-8. PubMed ID: 1940960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study.
    Tazaki Y; Sakai F; Otomo E; Kutsuzawa T; Kameyama M; Omae T; Fujishima M; Sakuma A
    Stroke; 1988 Feb; 19(2):211-6. PubMed ID: 3278412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebral protection by CDP choline during surgical action].
    Neidhardt A; Combe M; Combe J; Schipmann N
    Agressologie; 1986 Jun; 27(7):613-5. PubMed ID: 3777355
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rheographic evaluation of the cerebral angio-hemodynamic effects of cytidine diphosphate choline in arteriosclerotic ictal syndromes].
    De Gregorio G; Armeli G; Restivo S; Francolino A
    Boll Soc Ital Cardiol; 1977; 22(3):341-5. PubMed ID: 617280
    [No Abstract]   [Full Text] [Related]  

  • 12. [CDP choline in cerebral vasculopathy: clinical evaluation and instrumental semeiology].
    Corso EA; Arena M; Ventimiglia A; Bizzarro G; Campo G; Rodolico F
    Clin Ter; 1982 Aug; 102(4):379-86. PubMed ID: 6754218
    [No Abstract]   [Full Text] [Related]  

  • 13. CDP-choline: pharmacological and clinical review.
    Secades JJ; Frontera G
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDP-choline: repeated oral dose tolerance studies in adult healthy volunteers.
    Dinsdale JR; Griffiths GK; Castelló J; Maddock J; Ortiz JA; Aylward M
    Arzneimittelforschung; 1983; 33(7A):1061-5. PubMed ID: 6684468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases.
    Lozano Fernández R
    Arzneimittelforschung; 1983; 33(7A):1073-80. PubMed ID: 6684470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of methyl-14C CDP-choline by oral route.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1045-7. PubMed ID: 6684463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of repeatedly given CDP-choline on cardiovascular and tissue injury in spinal shock conditions: investigation of the acute phase.
    Coskun C; Avci B; Ocak N; Yalcin M; Dirican M; Savci V
    J Pharm Pharmacol; 2010 Apr; 62(4):497-506. PubMed ID: 20604840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine.
    Saligaut C; Daoust M; Chadelaud M; Moore N; Chretien P; Boismare F
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):5-8. PubMed ID: 3990445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the effect of CDP in patients with motor disorders of cerebral origin].
    Asirón Yribarren PJ; Bascuas Asta JL; Marín Górriz F; Marín Redondo J; Noguera Lobera AR; Ramos Cristóbal JA
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1978; 6(1):97-104. PubMed ID: 654990
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological study of CDP-choline. Protection against toxicity in a model of experimental hypoxia.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1022-4. PubMed ID: 6684455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.